These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 18710898)
1. Comment on: Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance. Kobelt G Rheumatology (Oxford); 2008 Oct; 47(10):1589-90; author reply 1590; discussion 1590-1. PubMed ID: 18710898 [No Abstract] [Full Text] [Related]
2. Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidance. Wailoo A; Bansback N; Chilcott J Rheumatology (Oxford); 2008 Feb; 47(2):119-20. PubMed ID: 18208819 [No Abstract] [Full Text] [Related]
3. [Anti-TNF alfa therapy in ankylosing spondylitis]. Cravo AR; Tavares V; Da Silva JC Acta Med Port; 2006; 19(2):141-50. PubMed ID: 17187716 [TBL] [Abstract][Full Text] [Related]
4. Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice. Elewaut D; Matucci-Cerinic M Rheumatology (Oxford); 2009 Sep; 48(9):1029-35. PubMed ID: 19561158 [TBL] [Abstract][Full Text] [Related]
5. Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice. Escudero-Vilaplana V; Ramírez-Herráiz E; Alañón-Plaza E; Trovato-López N; García-Vicuña R; Carreño-Pérez L; Morell-Baladrón A; Sanjurjo-Sáez M Int J Clin Pharm; 2015 Oct; 37(5):808-14. PubMed ID: 25910480 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor necrosis factor alpha and ankylosing spondylitis. Marzo-Ortega H; Emery P; McGonagle D N Engl J Med; 2003 Jan; 348(4):359-61; author reply 359-61. PubMed ID: 12542065 [No Abstract] [Full Text] [Related]
7. Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification? Van den Bosch F; De Keyser F; Mielants H; Veys EM Arthritis Res Ther; 2005; 7(3):121-3. PubMed ID: 15899063 [TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor inhibitors in ankylosing spondylitis. Reed MR; Taylor AL Intern Med J; 2008 Oct; 38(10):781-9. PubMed ID: 18422565 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in Germany. Neilson AR; Sieper J; Deeg M Rheumatology (Oxford); 2010 Nov; 49(11):2122-34. PubMed ID: 20660498 [TBL] [Abstract][Full Text] [Related]
10. The treatment of ankylosing spondylitis. Scalapino KJ; Davis JC Clin Exp Med; 2003 Feb; 2(4):159-65. PubMed ID: 12624705 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the treatment effect of NSAIDs/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysis. Escalas C; Trijau S; Dougados M Rheumatology (Oxford); 2010 Jul; 49(7):1317-25. PubMed ID: 20360041 [TBL] [Abstract][Full Text] [Related]
12. Alopecia areata during etanercept therapy. Pan Y; Rao NA Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875 [TBL] [Abstract][Full Text] [Related]
13. Are there new emerging drugs for ankylosing spondylitis or spondyloarthritis? Wendling D Expert Opin Emerg Drugs; 2013 Mar; 18(1):5-7. PubMed ID: 23216081 [TBL] [Abstract][Full Text] [Related]